South Africa Cardiac Resynchronization Therapy Market

South Africa Cardiac Resynchronization Therapy Market


$ 3999

South Africa Cardiac Resynchronization Therapy Market valued at $31 Mn in 2022, projected to reach $51 Mn by 2030 with a 6.23% CAGR. The significant rise in global heart failure instances, linked to the aging population and cardiovascular issues related to lifestyle, plays a crucial role in propelling the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major players in this market include Abbott, Boston Scientific, Medtronic, Biotronik, Siemens Healthineers, St. Jude Medical, LivaNova, Sorin Group, Oscor, and Lepu Medical Technology.

ID: IN10ZAPH443 CATEGORY: Pharmaceuticals GEOGRAPHY: South Africa AUTHOR: Dr. Medha Sansanwal

Buy Now

South Africa Cardiac Resynchronization Therapy Market Executive Summary

South Africa Cardiac Resynchronization Therapy Market valued at $31 Mn in 2022, projected to reach $51 Mn by 2030 with a 6.23% CAGR.

Cardiac resynchronization therapy (CRT) is a medical procedure utilizing a pacemaker to correct the heart's rhythm through a minimally invasive surgical approach. Implanted beneath the skin, the CRT pacemaker works to synchronize the timing between the upper and lower heart chambers, promoting coordination between the left and right sides of the heart. This intervention proves particularly advantageous for individuals experiencing heart failure, effectively addressing issues such as inadequate pumping and fluid retention in the lungs and legs resulting from the asynchronous beating of the heart's lower chambers. In instances of severe heart rhythm irregularities, the CRT therapy may be complemented by the addition of an implantable cardioverter-defibrillator (ICD). The CRT device connects wires from the pacemaker to both sides of the heart, employing biventricular pacing to ensure synchronized contractions and optimize overall heart function.

Cardiovascular disease (CVD), including heart attacks and strokes, is the second leading cause of death in South Africa. Five people experience a heart attack every hour, resulting in ten fatalities, while high blood pressure affects one in three South Africans over 15. Heart attacks lead to approximately 33 daily deaths, and strokes contribute to 60 fatalities. High blood pressure is the leading risk factor for heart attacks, accounting for 42% of cases, alongside other major risk factors such as an unhealthy diet, physical inactivity, smoking, obesity, and diabetes. Societal factors like poverty, limited healthcare access, and unhealthy living environments exacerbate the problem, emphasizing the urgent need for comprehensive strategies to address these challenges and reduce the impact of CVD on the population.

In South Africa, a multicenter study is comparing the effectiveness of CRT-defibrillators (CRT-Ds) versus CRT-pacemakers (CRT-Ps) in preventing heart failure hospitalizations to inform treatment guidelines and resource allocation decisions. Additionally, there's a growing interest in using telehealth technologies for remote monitoring of patients with CRT devices to improve outcomes and reduce healthcare costs. Pilot studies are underway to assess the feasibility and effectiveness of implementing remote monitoring in South Africa, collectively advancing cardiovascular care and optimizing healthcare resource allocation.

South Africa cardiac resynchronization therapy market

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Cardiovascular Diseases: cardiovascular disease (CVD), encompassing heart attacks and strokes, stands as the second most prevalent cause of mortality in South Africa. Every hour, 5 individuals in the country suffer a heart attack, leading to 10 fatalities. The increasing incidence of cardiovascular disease (CVD) serves as a significant driver for the growth of the CRT market in South Africa.

Technological Advancements: In South Africa, Abbott introduced the Encora III CRT-P device, incorporating Bluetooth connectivity and remote monitoring capabilities. The latest generation of CRT devices is characterized by a more compact size, enhanced efficiency, and added features such as remote monitoring. These technological advancements not only contribute to improved patient outcomes but also play a pivotal role in propelling market growth.

Rising Investments and Support: Recognizing the significance of enhancing cardiac care accessibility, particularly in the realm of CRT, the National Department of Health (NDoH) in South Africa acknowledges the need for comprehensive efforts. The anticipated boost in the CRT market in the country is attributed to the presence of local distributors and the expanding initiatives aimed at raising public awareness about heart diseases.

Market Restraints

Elevated Expense of Devices and Procedures: The exorbitant costs associated with CRT devices and their implantation procedures frequently surpass the financial means of many South Africans, particularly those residing in disadvantaged communities. This creates a substantial obstacle to accessibility, exacerbating healthcare disparities.

Disparities in Healthcare Access: Discrepancies in geographical locations and socioeconomic status contribute to uneven access to quality healthcare, including specialized cardiac care and CRT procedures. Individuals in rural areas and lower-income brackets often encounter significant difficulties in obtaining this life-saving therapy.

Insufficient Availability of Trained Professionals: A shortage of proficient cardiologists and technicians with expertise in CRT procedures remains a critical bottleneck. This shortage restricts the number of patients who can receive treatment and impedes the broader implementation of this technology.

Healthcare Policies and Regulatory Landscape

In South Africa, the oversight of healthcare policies and regulations for therapeutic drugs falls under the jurisdiction of the South African Health Products Regulatory Authority (SAHPRA). SAHPRA is responsible for the registration, licensing, and post-market surveillance of various health products, with a particular focus on pharmaceuticals. The Department of Health (DoH) plays a pivotal role in shaping healthcare policies, and adherence to Good Manufacturing Practice (GMP) standards is essential for pharmaceutical manufacturers to guarantee the quality and safety of therapeutic drugs. SAHPRA regulates clinical trials, and the ongoing implementation of the National Health Insurance (NHI) in South Africa has the potential to impact the financing and reimbursement policies associated with specific drugs.

Competitive Landscape

Key Players

  • Abbott
  • Boston Scientific
  • Medtronic
  • Biotronik
  • Siemens Healthineers
  • St. Jude Medical
  • LivaNova
  • Sorin Group
  • Oscor
  • Lepu Medical Technology

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

South Africa Cardiac Resynchronization Therapy Market Segmentation

By Product

  • CRT-Defibrillator
  • CRT-Pacemaker

By Age

  • Below 44 years
  • 45-64 years
  • 65-84 years
  • Above 85 years

By End-Users

  • Hospitals
  • Cardiac care Centres
  • Ambulatory Surgical Centres

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 01 January 1970
Updated by: Dr. Purav Gandhi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up